Advancements in Testing Strategies for COVID-19

Area of Science:

• * Virology and Infectious Diseases
• * Diagnostic Technologies
• * Public Health

Background:

• * Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, poses a significant global health threat.
• * The emergence of new SARS-CoV-2 variants necessitates continuous development of advanced diagnostic tools.
• * Current diagnostic strategies require improvement in terms of speed, cost-effectiveness, sensitivity, and accessibility.

Purpose of the Study:

• * To review and categorize existing diagnostic platforms for SARS-CoV-2 detection.
• * To analyze the principles, advancements, applications, and limitations of each diagnostic category.
• * To assess the impact of viral variants on diagnostic accuracy and explore future directions in diagnostic technology.

Main Methods:

• * Comprehensive literature review of diagnostic methodologies for SARS-CoV-2.
• * Categorization of diagnostic platforms into four main groups: imaging, molecular-based detection, serological testing, and biosensors.
• * Detailed analysis of the performance, challenges, and commercial availability of various diagnostic kits.

Main Results:

• * Diagnostic platforms vary in sensitivity, specificity, cost, and turnaround time.
• * Molecular-based detection and biosensors show high sensitivity and specificity for detecting active infections.
• * Serological testing is valuable for identifying past infections and immune responses, while imaging plays a supportive role.

Conclusions:

• * No single diagnostic platform is ideal for all scenarios; a combination of approaches may be necessary.
• * Ongoing research is crucial for developing more rapid, sensitive, and affordable diagnostic tools to combat current and future viral outbreaks.
• * Understanding the impact of SARS-CoV-2 variants on diagnostic performance is essential for accurate disease monitoring.